Cargando…
Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review
We previously designed and synthesized dehydroxyepoxyquinomicin (DHMEQ) as an inhibitor of NF-κB based on the structure of microbial secondary metabolite epoxyquinomicin C. DHMEQ showed anti-inflammatory and anticancer activity in various in vivo disease models without toxicity. On the other hand, t...
Autores principales: | Lin, Yinzhi, Ukaji, Tamami, Koide, Naoki, Umezawa, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877590/ https://www.ncbi.nlm.nih.gov/pubmed/29510517 http://dx.doi.org/10.3390/ijms19030729 |
Ejemplares similares
-
The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells
por: Lin, Yinzhi, et al.
Publicado: (2021) -
Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration
por: Umezawa, Kazuo, et al.
Publicado: (2020) -
Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ
por: Lin, Yinzhi, et al.
Publicado: (2023) -
Inhibition of Canonical NF-κB Nuclear Localization by (−)-DHMEQ via Impairment of DNA Binding
por: Horie, Kana, et al.
Publicado: (2015) -
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
por: Ma, Jun, et al.
Publicado: (2021)